Research Article

Tumor Size as a Critical Prognostic Factor in T1-2 Stage Esophageal Cancer

Table 1

Baseline characteristics of esophagus cancer patients by T stage.

All (%)T1 (%)T2 (%)T3 (%)T4 (%)TX (%)

Age (year)65.666.765.964.863.967.3
Sex
Male14192 (79.5)3732 (78.7)1521 (74.3)5177 (81.4)1873 (79.0)1889 (78.0)
Female3653 (20.5)1013 (21.3)527 (25.7)1181 (18.6)498 (21.0)534 (22.0)
Histology
SCN5862 (32.8)1482 (31.2)601 (29.3)1898 (29.9)1018 (42.9)863 (35.6)
ANA10442 (58.5)2889 (60.9)1223 (59.7)3896 (61.3)1112 (46.9)1322 (54.6)
EN568 (3.2)165 (3.5)30 (1.5)127 (2.0)110 (4.6)136 (5.6)
CMSN812 (4.6)180 (3.8)77 (3.8)373 (5.9)108 (4.6)74 (3.1)
CEN161 (0.9)29 (0.6)17 (0.8)64 (1.0)23 (1.0)28 (1.1)
Grade
Grade I898 (5.0)359 (7.6)107 (5.2)257 (4.0)99 (4.2)76 (3.1)
Grade II6481 (36.3)1832 (38.6)841 (41.1)2275 (35.8)784 (33.1)749 (30.9)
Grade III-IV7786 (43.6)1781 (37.5)737 (36.0)3033 (47.7)1066 (45.0)1169 (48.2)
Unknown2680 (15.0)773 (16.3)263 (12.8)793 (12.5)422 (17.8)429 (17.7)
N stage
N03491 (19.6)1181 (24.9)605 (29.5)1473 (23.2)177 (7.5)54 (2.2)
N11416 (8.0)239 (5.0)229 (11.2)808 (12.7)111 (4.7)29 (1.2)
N2645 (3.6)39 (0.8)74 (3.6)474 (7.5)54 (2.3)4 (0.2)
N3346 (1.9)9 (0.2)21 (1.0)269 (4.2)44 (1.9)3 (0.1)
NX11837 (66.3)3258 (68.7)1010 (49.3)3304 (52.0)1974 (83.3)2291 (94.6)
M stage
M012321 (69.0)3498 (73.7)1686 (82.3)5103 (80.3)1207 (50.9)827 (34.1)
M15368 (30.1)1247 (26.3)262 (12.8)1255 (19.7)1164 (49.1)1440 (59.4)
MX156 (0.9)0 (0.0)0 (0.0)0 (0.0)0 (0.0)156 (6.4)
Tumor size (cm), median (IQR)5.01 (3.0-6.5)4.04 (1.8-5.2)4.18 (2.2-5.0)5.16 (3.2-6.5)6.38 (4.0-8.0)5.85 (4.0-7.2)
LNE
0-212458 (69.8)3441 (27.6)1110 (54.2)3546 (55.8)2042 (86.1)2319 (95.7)
>25169 (28.7)1252 (24.4)812 (39.6)2746 (43.2)304 (12.8)55 (2.3)
Surgery status
No surgery11468 (64.3)2863 (25.0)984 (48.0)3307 (52.0)2007 (84.6)2307 (95.2)
Local tumor ED502 (2.8)400 (80.0)28 (1.4)28 (0.4)199 (8.4)27 (1.1)
Esophagectomy1508 (8.5)412 (27.3)262 (12.8)732 (11.5)74 (3.1)28 (1.1)
Esophagectomy LG4319 (24.2)1050 (24.3)670 (32.7)2283 (35.9)267 (11.3)49 (2.0)